ClinicalTrials.gg
RecruitingNCT07950345Updated Nov 20, 2026

Effect of Front-of-Package Labels on Intent to Purchase Packaged Foods in the Philippines

An interventional study of Nutrient Warning Label and Multiple Traffic Light label in Food Labeling, Diet, Healthy and Consumer Behavior, sponsored by Johns Hopkins Bloomberg School of Public Health. Recruiting at 3 sites in Philippines. Open to participants aged 18 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.

Primary conditionObesityRegistry: Consumer BehaviorReclassifiedWhy we changed it
Registry
Consumer Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Obesity
Why
  1. Consumer Behavior is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Obesity.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Johns Hopkins Bloomberg School of Public Health · Not applicable, Interventional, and Prevention

How we know

Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,105
Allocation
Randomized
Ages
18 Years to 59 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 22 studies in Obesity by Johns Hopkins Bloomberg School of Public Health — 1 open to participants now, 1 under way, none of them phase 3. Obesity · Johns Hopkins Bloomberg School of Public Health.

Planned enrollment
Largest of 19
2,105 · median 136
Started
2026
the only one that year
No phase
19 of 22
1 open now
Registered
22nd of 22
by date

Among the 22 studies in Obesity by Johns Hopkins Bloomberg School of Public Health, this one has the largest planned enrollment of the 19 interventional ones that give a count, is the only one that started in 2026, is one of 19 with no phase, and was the 22nd registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

1 of the 22 studies in Obesity by Johns Hopkins Bloomberg School of Public Health is open now, in 1 country.

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 59 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Obesity by Johns Hopkins Bloomberg School of Public Health, or all of them as a file.
02

Study summary

The Philippines is considering a mandatory front-of-package label (FoPL) for packaged foods. This randomized controlled trial will test which label design best helps consumers avoid products high in sugar, sodium, or saturated fat. Adults who buy packaged foods will be approached outside supermarkets and other food retailers in three locations: the City of Manila, Iloilo City, and the Municipality of San Jose, Dinagat Islands. After consent, each participant will be randomly assigned to one of five groups and will view mock packaged food products on a tablet: no label (control), a Nutrient Warning Label, a Multiple Traffic Light label, a Health Star Rating, or a Nutri-Grade style label. The main outcome is how likely participants say the participant is to buy products that contain nutrients of concern in excess. The study will also measure whether participants can correctly identify which nutrients are in excess, which of two similar products the participant would buy, and which product the participant thinks is healthier. Results will inform FoPL policy in the Philippines.

Read the detailed description

This is a five-arm, parallel-group, individually randomized trial with a single study visit of about 25 minutes. Trained research assistants recruit participants using street-intercept methods outside food retailers, screen for eligibility, and obtain written informed consent. Participants are randomized 1:1:1:1:1 in REDCap, stratified by study site, using an allocation table generated by an independent statistician; the enumerator does not know the allocation sequence in advance.

Within the assigned arm, participants complete: (1) single-product tasks, in which the participant views one mock product at a time (product order randomized), rate the intent to purchase on a 7-point scale, and indicate whether the product contains sugar, sodium, saturated fat, or protein in excess (protein is a distractor and is never in excess); (2) paired-product comparison tasks, in which, for three pairs of similar products showing different versions of the same label system, the participant's choose which product the participant would buy, which is healthier, and which the participant would be more worried about a child consuming; and (3) label acceptability questions, a label comparison task, and demographic questions. The Pan American Health Organization (PAHO) Nutrient Profile Model is used as an independent standard to classify products as containing sugar, sodium, or saturated fat in excess.

Sample size: 2,105 participants (approximately 701 per site; 421 per arm). This provides 80% power to detect a 0.36-point difference in mean intent to purchase (SD 1.5) for each label versus no label (Bonferroni alpha = 0.0125) and for pairwise comparisons among effective labels (alpha = 0.0083).

Primary analysis: a linear model of each participant's mean purchase-intent score across four products, with treatment arm as a fixed effect and no label as the reference category (four primary contrasts), adjusting for pre-specified baseline covariates that are imbalanced across arms. Multiplicity is controlled using the Hochberg step-down procedure. If any label is effective compared with no label, effective labels are compared pairwise (up to six contrasts). Statisticians are blinded to arm assignment for the primary outcome analysis.

03

Conditions studied

  • Food Labeling
  • Diet, Healthy
  • Consumer Behavior
  • Obesity
  • Noncommunicable Diseases

Browse trials for

Keywords

  • front-of-package labeling
  • nutrient warning label
  • traffic light label
  • Health Star Rating
  • Nutri-Grade
  • purchase intention
  • packaged foods
  • Philippines
04

In context

Obesity Reclassified

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

This study's planned enrollment of 2,105 is above the median of 67 across 9,043 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Johns Hopkins Bloomberg School of Public Health is the lead sponsor of 371 studies on the registry; 41 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Consumer Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 59 years
  • Purchases packaged foods
  • Resident of the Philippines
  • Able and willing to provide written

Exclusion criteria

Exclusion Criteria:

  • Age under 18 or over 59 years
  • Does not purchase packaged foods
  • Not a resident of the Philippines
  • Adults lacking capacity to consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
2,105 participants (estimated)

Study arms

  • No intervention
    No label (control)

    Participants view mock packaged food products without any front-of-package label.

  • Experimental
    Nutrient Warning Label (NWL)

    Mock packaged food products display black octagonal warning labels for each nutrient (sugar, sodium, saturated fat) present in excess.

    Behavioral: Nutrient Warning Label

  • Experimental
    Multiple Traffic Light (MTL)

    Mock packaged food products display a Multiple Traffic Light label with red, amber, or green color coding of sugar, sodium, and saturated fat levels.

    Behavioral: Multiple Traffic Light label

  • Experimental
    Health Star Rating (HSR)

    Mock packaged food products display a Health Star Rating summary score (0.5 to 5 stars).

    Behavioral: Health Star Rating label

  • Experimental
    Nutri-Grade style (NG)

    Mock packaged food products display a Nutri-Grade style letter-grade label.

    Behavioral: Nutri-Grade style label

Interventions

  • BehavioralNutrient Warning Label

    Front-of-package warning symbols flagging each nutrient of concern (sugar, sodium, saturated fat) that exceeds the label's nutrient profile threshold, applied to mock packaged food images shown on a tablet during a single study visit.

    Also known as: NWL

  • BehavioralMultiple Traffic Light label

    Front-of-package label showing levels of sugar, sodium, and saturated fat color-coded red, amber, or green, applied to mock packaged food images shown on a tablet during a single study visit.

    Also known as: MTL

  • BehavioralHealth Star Rating label

    Front-of-package summary rating from 0.5 to 5 stars based on an underlying nutrient profile algorithm, applied to mock packaged food images shown on a tablet during a single study visit.

    Also known as: HSR

  • BehavioralNutri-Grade style label

    Front-of-package letter-grade summary label (Nutri-Grade style), applied to mock packaged food images shown on a tablet during a single study visit.

    Also known as: NG

07

What researchers measure

Primary outcomes

  1. Mean Self-Reported Intent to Purchase Products Containing Nutrients of Concern in Excess

    After viewing each of four mock packaged products containing sugar, sodium, and/or saturated fat in excess (per the PAHO Nutrient Profile Model), participants answer: "Imagine you were looking to buy \[product\]. Would you buy this product for yourself or your family?" on a fully labeled 7-point scale (1 = I would certainly not buy this product; 4 = Neutral; 7 = I would definitely buy this product). The outcome is the participant's mean score across the four products (range 1-7; higher scores indicate greater intent to purchase). Each front-of-package label arm is compared with the no-label control.

    Time frame: During the single study visit (Day 1, approximately 25 minutes)

Secondary outcomes

  1. Accuracy in Identifying Nutrients of Concern Present in Excess

    For each single-product task, participants report whether the product contains sugar, sodium, saturated fat, and protein in excess (Yes / No / I don't know). Reported as the proportion of correct identifications (sensitivity and overall accuracy) per nutrient and pooled across products, compared between each label arm and no label and among effective labels. "I don't know" is counted as incorrect. Protein is never in excess; the false-positive rate for protein is also reported.

    Time frame: During the single study visit (Day 1)

  2. Selection of the Healthier Product for Purchase in Paired Product Comparisons

    For each of three pairs of similar products showing different versions of the assigned label system (e.g., fewer vs. more warnings), participants choose which product the participant would buy (Product A / Product B / Either / Neither). Outcome: selection of the healthier product (1) vs. any other response (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).

    Time frame: During the single study visit (Day 1)

  3. Correct Identification of the Healthier Product in Paired Product Comparisons

    For each of three product pairs, participants choose which product is healthier (Product A / Product B / I don't know). Outcome: correct choice (1) vs. incorrect choice or "I don't know" (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).

    Time frame: During the single study visit (Day 1)

  4. Concern About Child Consumption in Paired Product Comparisons (proportion of participants selecting the less healthful product)

    For each of three product pairs, participants choose which product the participant would be more worried about letting a child consume (Product A / Product B / I don't know). Reported as the proportion selecting the less healthful product, by arm.

    Time frame: During the single study visit (Day 1)

08

Study locations

1 of 3 sites recruiting
  • Municipality of San Jose, Dinagat Islands
    San Jose, Dinagat Islands, Philippines
    Not yet recruiting
  • Iloilo City
    Iloilo City, Iloilo, Philippines
    Not yet recruiting
  • City of Manila
    Manila, National Capital Region, Philippines
    Recruiting
09

References and documents

Individual participant data

Plan to share: No — Under the Institutional Review Board (IRB) approved data management plan, individual participant data will not be shared with investigators outside the study team.

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for Dec 2026, 1 month after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 1 month is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2026
First posted
Nov 20, 2026
StartActual
Nov 15, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Jun 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07950345
Collaborators
University of the Philippines Manila, Resolve to Save Lives
Responsible party
Sponsor
First posted
Nov 20, 2026
Start date
Nov 15, 2026
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Megan E Henry, PhD
Contact
mhenry16@jh.edu
Megan E Henry, PhD
principal investigator · Johns Hopkins Bloomberg School of Public Health
TJ Robinson Moncatar, RN, MPH, PhD
principal investigator · University of the Philippines Manila, College of Public Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion